J.C. Walter Jr. Transplant Center

Medicine & Life Sciences

1. Kidney 100%
2. Transplants 99%
3. Liver Transplantation 71%
4. Allografts 68%
5. Transplant Recipients 55%
6. Tissue Donors 48%
7. T-Lymphocytes 42%
8. Kidney Transplantation 40%
9. Heart Failure 34%
10. Transplantation 33%
11. Lung 33%
12. Pancreas Transplantation 32%
13. Heart-Assist Devices 30%
14. Living Donors 29%
15. Pancreas 28%
16. Therapeutics 25%
17. Neoplasms 24%
18. Heart 24%
19. Pulmonary Arterial Hypertension 21%
20. Immunosuppression 21%
21. Sirolimus 19%
22. Oocytes 18%
23. Cyclosporine 18%
24. Survival 18%
25. Graft Survival 18%
26. Macrophages 17%
27. Biopsy 17%
28. Graft Rejection 17%
29. Liver 16%
30. Pulmonary Hypertension 16%
31. Xenopus 16%
32. Antibodies 16%
33. Transplantation Tolerance 15%
34. Regulatory T-Lymphocytes 15%
35. Renal Cell Carcinoma 14%
36. Proteins 14%
37. RNA 14%
38. Fibrosis 13%
39. Organ Transplantation 13%
40. Immunosuppressive Agents 13%
41. Hepatocellular Carcinoma 12%
42. Xenopus laevis 12%
43. Tacrolimus 12%
44. Cytokines 12%
45. Mortality 12%
46. Genes 11%
47. Messenger RNA 11%
48. thymoglobulin 11%
49. Coronavirus 11%
50. Heart Transplantation 11%
51. Tumor Necrosis Factor-alpha 11%
52. Incidence 11%
53. Creatinine 11%
54. Wounds and Injuries 11%
55. Inflammation 10%
56. Surgeons 10%
57. Lung Injury 10%
58. Blood Vessels 10%
59. Adenocarcinoma 10%
60. Hemodynamics 10%
61. Prostatic Neoplasms 10%
62. Apoptosis 9%
63. Chronic Kidney Failure 9%
64. Hyperoxia 9%
65. Germ Cells 9%
66. Registries 9%
67. Cardiomyopathies 9%
68. B-Lymphocytes 9%
69. Serum 9%
70. Prostate 8%
71. Lung Transplantation 8%
72. Chronic Renal Insufficiency 8%
73. Dendritic Cells 8%
74. Phenotype 8%
75. Psychology Rejection 8%
76. Drainage 8%
77. Interleukin-2 8%
78. Infections 8%
79. Type 1 Diabetes Mellitus 8%
80. Pandemics 8%
81. Glomerulonephritis 8%
82. Animals 8%
83. Pediatrics 8%
84. Idiopathic Pulmonary Fibrosis 8%
85. Mycophenolic Acid 8%
86. Glomerular Filtration Rate 8%
87. Recurrence 8%
88. Safety 8%
89. Carcinoma 8%
90. Islets of Langerhans 8%
91. Staining and Labeling 8%
92. Morbidity 7%
93. End Stage Liver Disease 7%
94. Hepatitis C 7%
95. tezosentan 7%
96. Islets of Langerhans Transplantation 7%
97. Pancreatitis 7%
98. Transgenic Mice 7%
99. Education 7%
100. Hypertension 7%